NuCana PLC Sustainability Reports
NuCana plc is a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer. The company applies its proprietary ProTide technology to develop safer and more effective anti-cancer medicines.
Sector: Manufacturing
Country: United Kingdom
Exchange: Nasdaq
LEI: 213800K5NF92PPHPA304
2 reports from 2017 to 2024
Company Profile
NuCana plc is a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer. The company applies its proprietary ProTide technology to develop safer and more effective anti-cancer medicines.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
